|
IPO11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.240800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.458400E-01 |
| Normal-vs-Stage2 |
1.651840E-01 |
| Normal-vs-Stage3 |
2.800300E-02 |
| Normal-vs-Stage4 |
5.380400E-03 |
| Stage1-vs-Stage2 |
3.405200E-01 |
| Stage1-vs-Stage3 |
2.680300E-03 |
| Stage1-vs-Stage4 |
1.363540E-03 |
| Stage2-vs-Stage3 |
2.363500E-03 |
| Stage2-vs-Stage4 |
7.585300E-04 |
| Stage3-vs-Stage4 |
3.292200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.320400E-01 |
| Normal-vs-AfricanAmerican |
7.891200E-01 |
| Normal-vs-Asian |
9.984800E-01 |
| Caucasian-vs-AfricanAmerican |
4.453600E-01 |
| Caucasian-vs-Asian |
5.150800E-01 |
| AfricanAmerican-vs-Asian |
8.149800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.524400E-01 |
| Normal-vs-Female |
9.626400E-01 |
| Male-vs-Female |
3.015400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.165400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.030000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.675400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.507200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.440800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.171500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.777800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.619200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.144800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.205800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.96700999999244E-05 |
| Classical-VS-Follicular |
8.378400E-02 |
| Classical-VS-Other |
1.431010E-01 |
| Classical-VS-Normal |
9.611000E-01 |
| Tall-VS-Follicular |
1.37190000004672E-06 |
| Tall-VS-Other |
7.720200E-01 |
| Tall-VS-Normal |
7.68899999999961E-05 |
| Follicular-VS-Other |
7.974000E-02 |
| Follicular-VS-Normal |
1.321990E-01 |
| Other-VS-Normal |
4.437800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.607400E-01 |
| Normal-vs-N1 |
4.289700E-02 |
| N0-vs-N1 |
3.211900E-02 |
|
|
